United States · Bill · S
S. 2569 (110th)
Ovarian Cancer Biomarker Research Act of 2008
Introduced
29 January 2008
Last action
29 January 2008 · Introduced
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsors
Sen. Boxer, Barbara [D-CA], Sen. Dole, Elizabeth [R-NC], Sen. Tester, Jon [D-MT], Sen. Murray, Patty [D-WA], Sen. Wyden, Ron [D-OR], Sen. Cantwell, Maria [D-WA], Sen. Stabenow, Debbie [D-MI], Sen. Obama, Barack [D-IL], Sen. Sanders, Bernard [I-VT], Sen. Bayh, Evan [D-IN], Sen. Whitehouse, Sheldon [D-RI], Sen. Clinton, Hillary Rodham [D-NY], Sen. Menendez, Robert [D-NJ], Sen. Collins, Susan M. [R-ME], Sen. Inouye, Daniel K. [D-HI], Sen. Schumer, Charles E. [D-NY], Sen. Dodd, Christopher J. [D-CT], Sen. Cardin, Benjamin L. [D-MD], Sen. Lautenberg, Frank R. [D-NJ]
Subjects
Healthcare
Source updated
14 August 2025
Summary
Ovarian Cancer Biomarker Research Act of 2008 - Amends the Public Health Service Act to require the Director of the National Cancer Institute to enter into cooperative agreements with, or make grants to, public or nonprofit entities to establish and operate centers to conduct research on biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer. Designates each center as an Ovarian Cancer Biomarker Center of Excellence. Allows federal payments under such an agreement or grant to be used for research on: (1) the development and characterization of new biomarkers and the refinement of existing biomarkers; (2) the clinical and laboratory validation of such biomarkers; (3) the development and implementation of clinical and epidemiological research on the utilization of such biomarkers; and (4) the development and implementation of repositories for new tissue, urine, serum, and other biological specimens. Requires the Director to: (1) make available for research banked serum and tissue specimens from clinical research regarding ovarian cancer that was funded by the Department of Health and Human Services (HHS); (2) establish an Ovarian Cancer Biomarker Clinical Trial Committee, which shall be established and operated in consultation with the Gynecologic Oncology Group, to assist the Director to design and implement national clinical trials to determine the utility of such biomarkers; and (3) establish a national data center to conduct statistical analyses of trial data.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
29 January 2008
Introduced
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Source: IntroReferral
29 January 2008
Introduced
Sponsor introductory remarks on measure. (CR S448)
Source: IntroReferral
29 January 2008
Introduced
Introduced in Senate
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Introduced in Senate · 29 January 2008 · Download file
Documents
3 official files
Introduced in Senate (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in Senate (text)
Introduced in Senate · EN · 29 January 2008
Introduced in Senate (PDF)
Introduced in Senate · EN · 29 January 2008
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in Senate
summary · EN · 29 January 2008
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Sen. Boxer, Barbara [D-CA] · D · Sponsor
- Sen. Dole, Elizabeth [R-NC] · R · Sponsor
- Sen. Tester, Jon [D-MT] · D · Sponsor
- Sen. Murray, Patty [D-WA] · D · Sponsor
- Sen. Wyden, Ron [D-OR] · D · Sponsor
- Sen. Cantwell, Maria [D-WA] · D · Sponsor
- Sen. Stabenow, Debbie [D-MI] · D · Sponsor
- Sen. Obama, Barack [D-IL] · D · Sponsor
- Sen. Sanders, Bernard [I-VT] · I · Cosponsor
- Sen. Bayh, Evan [D-IN] · D · Cosponsor
- Sen. Whitehouse, Sheldon [D-RI] · D · Cosponsor
- Sen. Clinton, Hillary Rodham [D-NY] · D · Cosponsor
- Sen. Menendez, Robert [D-NJ] · D · Cosponsor
- Sen. Collins, Susan M. [R-ME] · R · Cosponsor
- Sen. Inouye, Daniel K. [D-HI] · D · Cosponsor
- Sen. Schumer, Charles E. [D-NY] · D · Cosponsor
- Sen. Dodd, Christopher J. [D-CT] · D · Cosponsor
- Sen. Cardin, Benjamin L. [D-MD] · D · Cosponsor
- Sen. Lautenberg, Frank R. [D-NJ] · D · Cosponsor
- · sshr00 · Standing
Related records
- related to → Ovarian Cancer Biomarker Research Act of 2007
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/110th-congress/senate-bill/2569
- Open data entity: https://api.congress.gov/v3/bill/110/s/2569
- us · 110-s-2569 · source updated 14 August 2025